2025 · International journal of cancer · open access
Recurrent cervical cancer detection using DNA methylation markers in self-collected samples from home
Schaafsma et al.
The finding, in our words
DNA methylation levels in self-collected cervicovaginal samples fell two years after treatment in patients who remained free of recurrent cervical cancer. This shows that home-collected urine and cervicovaginal specimens can be used to assess methylation markers for surveillance of cervical cancer recurrence.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.